Adverse Drug Reactions to Anti-tubercular Drugs in HIV/TB Co-infected Patients.

Chatrath, Anshul and Shenoy, Ashok K and *, John T Ramapuram and Chowta, Mukta N and Kamath, Ashwin (2016) Adverse Drug Reactions to Anti-tubercular Drugs in HIV/TB Co-infected Patients. Research Journal of Pharmaceutical, Biological and Chemical Sciences, 7 (2). pp. 1934-1937. ISSN 0975-8585

[img] PDF
http___rms.manipal.edu_PublicationEntry_DisplayPdf.aspx_val=__172.16.19.67_rmspdf_00000335_JA_08-03-16-11-51-26.pdf - Published Version
Restricted to Registered users only

Download (585kB) | Request a copy


The medications used to treat HIV and TB can result in significant adverse effects and drug interactions which can adversely impact the disease management. The objective of this study is to determine the adverse reactions to anti-tubercular drugs in these HIV/TB co-infected patients. A retrospective study of case record files of HIV/TB co-infected patients on anti-tubercular treatment was carried out at a tertiary care teaching hospital and a district government hospital. Demographic details and adverse drug reactions were recorded. Data of 96 HIV/TB co-infected patients on anti-tubercular therapy was evaluated. Of these, 44 (45.8%)developed adverse drug reaction during the course of treatment. Rifampicin was considered to be responsible for 63.6% of adverse drug reactions. Hepatitis was the most common adverse reaction (31.8%). Almost half of the patient population with HIV/TB co-infection on anti-tubercular drugs experienced an adverse drug reaction. Early recognition and management of the adverse drug reactions is important to decrease morbidity and mortality.

Item Type: Article
Uncontrolled Keywords: Adverse drug reaction, Anti-tubercular drugs, HIV, Hepatitis
Subjects: Medicine > KMC Mangalore > Pharmacology
Medicine > KMC Mangalore > Medicine
Depositing User: KMCMLR User
Date Deposited: 08 Mar 2016 15:11
Last Modified: 08 Mar 2016 15:11

Actions (login required)

View Item View Item